Literature DB >> 2262912

Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol.

H Jaeschke1.   

Abstract

Acetaminophen (500 mg/kg i.p.) induced hepatotoxicity in fasted ICR mice in vivo. Acetaminophen also caused a long-lasting 50% reduction of the hepatic ATP content, an irreversible loss of hepatic xanthine dehydrogenase activity and a transient increase of the xanthine oxidase activity. All effects occurred before parenchymal cell damage, i.e., the release of cellular enzymes. The hepatic content of GSH and GSSG was initially depleted by acetaminophen without affecting the GSSG:GSH ratio (1:200), however, during the recovery phase of the hepatic GSH levels the GSSG content increased faster than GSH, resulting in a GSSG:GSH ratio of 1:18 24 h after acetaminophen administration. The mitochondrial GSSG content increased from 2% in controls to greater than 20% in acetaminophen-treated mice. The extremely elevated tissue GSSG levels were accompanied by a 4-fold increase of the plasma GSSG concentrations but not by an enhanced biliary efflux, although hepatic GSSG formation and biliary excretion were not affected by acetaminophen. Allopurinol protected dose-dependently against acetaminophen-induced cell injury, the loss of ATP and the increase of the GSSG content in the total liver and in the mitochondrial compartment without inhibiting reactive metabolite formation. High, protective as well as low, nonprotective doses of allopurinol almost completely inhibited hepatic xanthine oxidase and dehydrogenase activity, but only high doses prevented the increase of the mitochondrial GSSG content. The data indicate a long-lasting, primarily intracellular oxidant stress during the progression phase of acetaminophen-induced cell necrosis. The protective effect of allopurinol is unlikely to involve the inhibition of reactive oxygen formation by xanthine oxidase but could be the result of its antioxidant property.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262912

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  123 in total

1.  Activation of autophagy protects against acetaminophen-induced hepatotoxicity.

Authors:  Hong-Min Ni; Abigail Bockus; Nikki Boggess; Hartmut Jaeschke; Wen-Xing Ding
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

2.  c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.

Authors:  Chieko Saito; John J Lemasters; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-25       Impact factor: 4.219

3.  Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.

Authors:  S Gupta; L K Rogers; S K Taylor; C V Smith
Journal:  Toxicol Appl Pharmacol       Date:  1997-10       Impact factor: 4.219

4.  Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.

Authors:  Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

5.  Mouse liver protein sulfhydryl depletion after acetaminophen exposure.

Authors:  Xi Yang; James Greenhaw; Qiang Shi; Dean W Roberts; Jack A Hinson; Levan Muskhelishvili; Kelly Davis; William F Salminen
Journal:  J Pharmacol Exp Ther       Date:  2012-10-23       Impact factor: 4.030

6.  Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.

Authors:  Kuo Du; Anup Ramachandran; James L Weemhoff; Hemantkumar Chavan; Yuchao Xie; Partha Krishnamurthy; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

7.  Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.

Authors:  Benjamin L Woolbright; Anup Ramachandran; Mitchell R McGill; Hui-min Yan; Mary Lynn Bajt; Matthew R Sharpe; John J Lemasters; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-09-25       Impact factor: 4.080

8.  Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice.

Authors:  Shubhra Chaudhuri; Sandra S McCullough; Leah Hennings; Aliza T Brown; Shun-Hwa Li; Pippa M Simpson; Jack A Hinson; Laura P James
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-10       Impact factor: 4.219

9.  Mechanism of protection by metallothionein against acetaminophen hepatotoxicity.

Authors:  Chieko Saito; Hui-Min Yan; Antonio Artigues; Maria T Villar; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-14       Impact factor: 4.219

10.  Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.

Authors:  Alice E Kane; Sarah J Mitchell; John Mach; Aniko Huizer-Pajkos; Catriona McKenzie; Brett Jones; Victoria Cogger; David G Le Couteur; Rafael de Cabo; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-11-23       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.